JESSICA BLAKE: Open Payments
NPI 1760154447 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$184 in 10 payments from 8 companies in 2025. Trend: 2023 $744 · 2024 $744 · 2025 $184
Food & beverage: $184
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Novo Nordisk Inc | 1 | $24 |
| Stryker Corporation | 1 | $22 |
| Lundbeck LLC | 1 | $20 |
| Abbott Laboratories | 1 | $20 |
| Amgen Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
Products named: FARXIGA, XIFAXAN, Ozempic, CLOTTRIEVER BOLD CATHETER, REXULTI, OTEZLA, CREON.
Industry payments across SC — which companies pay providers there.
